A Colombian hempire
Colombian companies might be missing an opportunity by ignoring hemp in favor of pharmaceutical-grade cannabis.
Local grow, global ambition: interview with Aras Azadian, Avicanna CEO
This month we speak to Aras Azadian, CEO of Avicanna, the only Colombian-focused LP listed on senior board of the Toronto Stock Exchange.
Strength in numbers
The outcry over the new INCB quota should not overshadow the publication of a white paper containing realistic industry predictions. The role of the INCB had been fundamentally misunderstood both…
Hora de un cambio: el proyecto de ley de cannabis recreativo
Una entrevista con: Armando Benedetti, senador del partido de la U, proponente del proyecto de ley para regular el consumo y expendio de cannabis recreativo. M: ¿Qué proceso ha tenido…
Allegiant Pharma
One US penny per gram of dry flower. That’s the bold production cost goal Allegiant Pharma have set for mechanized hemp cultivation at their project in Tolima, north of Bogotá.…
Seed genetics: Feeling the strain
Experts say that Colombia’s diverse climatic and soil conditions mean it has the opportunity to become a global cannabis seed bank, and companies are racing to breed the perfect strain.…
Angelo Investor
Known as the father of the cannabis industry, Steve DeAngelo is an entrepreneur, activist, author and on-screen personality. He co- founded several iconic cannabis businesses, including Harborside, one of the…
Early applicant
Formerly a talent manager for renowned Colombian musicians, Mauricio Krausz discovered the benefits of medical cannabis at Barcelona’s “Cannabis Clubs”. When the Colombian government legalized medicinal cannabis in 2015, Mauricio’s…
Colombia on the “right” side of the United States’ failed War on Drugs
Key industry figures write directly for our new viewpoint section. This month, a former DEA Drug Task Force Commander argues that countries that recognize the benefits of medicinal cannabis are…
